Adjuvant Radiotherapy in Centrally Located Hepatocellular Carcinomas after Hepatectomy with Narrow Margin (<1 cm): A Prospective Randomized Study - 19/02/14
Abstract |
Background |
Although radiotherapy (RT) provides potential benefits for patients with hepatocellular carcinomas (HCCs) that are unsuitable for operation, the specific role of adjuvant RT in HCC after hepatectomy remains ill defined. The current study's aim was to evaluate the safety and efficacy of adjuvant RT for centrally located HCCs after narrow-margin (<1 cm) hepatectomy.
Study Design |
The study included 119 patients with centrally located HCCs who underwent narrow-margin hepatectomy between July 2007 and March 2012. Patients were prospectively randomized to receive adjuvant RT (n = 58) or were assigned to a control group (n = 61). Surgical outcomes, safety, and survival rates were evaluated.
Results |
Hepatectomy was successfully performed in all patients. No cases of radiation-induced liver disease were observed. One-, 3-, and 5-year recurrence-free survival rates were 78.1%, 56.5%, and 36.9% in the adjuvant RT group and 72.4%, 40.1%, and 16.0% in the control group, respectively (p = 0.06, log-rank test). Corresponding overall survival rates were 96.2%, 72.6%, 48.4%, and 89.6%, 74.5%, 37.2%, respectively (p = 0.48, log-rank test). One-, 3-, and 5-year recurrence-free survival rates in patients with small-diameter tumors (≤5 cm) were 88.8%, 67.4%, 42.9% in the adjuvant RT group and 82.3%, 42.9%, 21.5% in the control group (p = 0.03, log-rank test). Corresponding overall survival rates were 97.5%, 75.3%, 75.3%, and 94.7%, 84.1%, 65.4%, respectively (p = 0.92, log-rank test).
Conclusions |
Adjuvant RT for centrally located HCCs after narrow-margin hepatectomy was technically feasible and relatively safe. No significant between-group difference was observed in recurrence-free and overall survival. The post-hoc subgroup comparison showed that adjuvant RT improved recurrence-free survival considerably, but not overall survival, in patients with small HCCs (≤5 cm). More in-depth studies are needed to validate this finding.
Le texte complet de cet article est disponible en PDF.Abbreviations and Acronyms : AFP, 3D-CRT, HCC, RT, TACE
Plan
| Disclosure Information: Nothing to disclose. |
|
| Supported by the Key Programs of the Cancer Institute and Hospital, Chinese Academy of Medical Science (grant number LC2010A15). |
|
| Drs Yu and Weihu Wang contributed equally to this work. |
Vol 218 - N° 3
P. 381-392 - mars 2014 Retour au numéro
Article précédent
- Evaluation of Initial Participation in Public Reporting of American College of Surgeons NSQIP Surgical Outcomes on Medicare's Hospital Compare Website
- Allison R. Dahlke, Jeanette W. Chung, Jane L. Holl, Clifford Y. Ko, Ravi Rajaram, Lynn Modla, Martin A. Makary, Karl Y. Bilimoria
- Interhospital Transfer and Adverse Outcomes after General Surgery: Implications for Pay for Performance
- Donald J. Lucas, Aslam Ejaz, Elliott R. Haut, Gaya Spolverato, Adil H. Haider, Timothy M. Pawlik
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?